Cargando…
SC83288 is a clinical development candidate for the treatment of severe malaria
Severe malaria is a life-threatening complication of an infection with the protozoan parasite Plasmodium falciparum, which requires immediate treatment. Safety and efficacy concerns with currently used drugs accentuate the need for new chemotherapeutic options against severe malaria. Here we describ...
Autores principales: | Pegoraro, Stefano, Duffey, Maëlle, Otto, Thomas D, Wang, Yulin, Rösemann, Roman, Baumgartner, Roland, Fehler, Stefanie K, Lucantoni, Leonardo, Avery, Vicky M, Moreno-Sabater, Alicia, Mazier, Dominique, Vial, Henri J, Strobl, Stefan, Sanchez, Cecilia P, Lanzer, Michael |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5290327/ https://www.ncbi.nlm.nih.gov/pubmed/28139658 http://dx.doi.org/10.1038/ncomms14193 |
Ejemplares similares
-
Erratum: SC83288 is a clinical development candidate for the treatment of severe malaria
por: Pegoraro, Stefano, et al.
Publicado: (2017) -
Profiling of the anti-malarial drug candidate SC83288 against artemisinins in Plasmodium falciparum
por: Duffey, Maëlle, et al.
Publicado: (2018) -
The need to compare: assessing the level of agreement of three high-throughput assays against Plasmodium falciparum mature gametocytes
por: Lucantoni, Leonardo, et al.
Publicado: (2017) -
HSQC-TOCSY Fingerprinting-Directed Discovery of Antiplasmodial Polyketides from the Marine Ascidian-Derived Streptomyces sp. (USC-16018)
por: Buedenbender, Larissa, et al.
Publicado: (2018) -
A simple and predictive phenotypic High Content Imaging assay for Plasmodium falciparum mature gametocytes to identify malaria transmission blocking compounds
por: Lucantoni, Leonardo, et al.
Publicado: (2015)